Anastasios Karlaftis

The 5-HT1A receptor agonist buspirone improves esophageal motor function and symptoms in systemic sclerosis: a 4-week, open-label trial

George Karamanolis, Stylianos Panopoulos, Konstantinos Denaxas et al. · Arthritis Research & Therapy · 2016 · 57 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +11

Beneficial effect of the 5‐HT_1A receptor agonist buspirone on esophageal dysfunction associated with systemic sclerosis: A pilot study

George Karamanolis, Stylianos Panopoulos, Anastasios Karlaftis et al. · United European Gastroenterology Journal · 2014 · 42 citations · Full text

Medicine, Pharmacotherapy, Motor Control +11

The impact of newer nucleos(t)ide analogues on patients with hepatitis B decompensated cirrhosis.

Εvangelos Cholongitas, George Papatheodoridis, John Goulis et al. · PubMed · 2015 · 28 citations

Pharmacy, Pharmacotherapy, Hepatic Pharmacotherapy +16

Clinical characteristics in patients with non-cardiac chest pain could favor gastroesophageal reflux disease diagnosis.

Anastasios Karlaftis, George Karamanolis, Κonstantinos Τriantafyllou et al. · PubMed · 2013 · 19 citations

Medicine, Clinical Sciences, Internal Medicine +12